Phase II Trial of a Paclitaxel-Carboplatin Combination in Recurrent Squamous Cell Carcinoma of the Head and Neck

Publisher： Karger

E-ISSN： 1423-0232|60|1|66-71

ISSN： 0030-2414

Source： Oncology, Vol.60, Iss.1, 2000-12, pp. : 66-71

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Weekly Paclitaxel and Carboplatin Combination Chemotherapy in Patients with Advanced Squamous Cell Carcinoma of the Head and Neck

By  

Oncology Research and Treatment, Vol. 26, Iss. 6, 2004-01 ,pp. : 568-572

Karger

Access to resources Recommend Favorite

Vinorelbine and Carboplatin in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

By  

Oncology, Vol. 56, Iss. 1, 1999-01 ,pp. : 24-27

Karger

Access to resources Recommend Favorite

Phase II Study with Docetaxel and Cisplatin in the Treatment of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

By  

Oncology, Vol. 63, Iss. 2, 2002-09 ,pp. : 145-150

Karger

Access to resources Recommend Favorite

Phase II study of bevacizumab in combination with docetaxel and radiation in locally advanced squamous cell carcinoma of the head and neck

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 11, 2015-11 ,pp. : 1665-1671

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase II Study of Cetuximab in Combination with Docetaxel in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck after Platinum-Containing Therapy: A Multicenter Study of the Arbeitsgemeinschaft Internistische Onkologie

By  

Oncology, Vol. 84, Iss. 5, 2013-02 ,pp. : 284-289

Karger

Access to resources Recommend Favorite